首页> 外文期刊>Indian drugs >1,3,7,8-SUBSTITUTED XANTHINE DERIVATIVES AS POTENTIAL ANTIASTHMATIC AGENTS WHICH ACT ON ADENOSINE RECEPTOR
【24h】

1,3,7,8-SUBSTITUTED XANTHINE DERIVATIVES AS POTENTIAL ANTIASTHMATIC AGENTS WHICH ACT ON ADENOSINE RECEPTOR

机译:1,3,7,8-取代的黄嘌呤衍生物作为对腺苷受体作用的潜在抗炎剂

获取原文
获取原文并翻译 | 示例
           

摘要

Asthma is one of the most common chronic diseases in modern society. There is a high prevalence of usage of complementary medicine for asthma. Xanthine derivatives which act on adenosine receptor have been cited as a most popular complementary treatment. This studys was undertaken to determine if there is any evidence for the clinical efficacy of xanthine derivatives for the treatment of asthma symptoms. This review highlights the more recent developments in the design and optimization of xanthine derivatives which act on A_2A and A_2B adenosine receptor. 1,3,8 and 1,3,7,8-substituted xanthine derivatives were found to be effetive. 1,3,7,8 Substituted xanthine derivative possess good affinity on A_2A and A_2B AR and are not selective for one particular receptor. This is benef itical for decreasing the side effects related to CVS.
机译:哮喘是现代社会中最常见的慢性疾病之一。 对哮喘互补药物的使用率很高。 作用于腺苷受体的黄嘌呤衍生物被认为是最受欢迎的互补治疗。 该研究旨在确定是否存在X原胺衍生物治疗哮喘症状的临床疗效的任何证据。 本综述突出了近期衍生物设计和优化的最新发展,其作用于A_2A和A_2B腺苷受体。 发现1,3,8和1,3,7,8-取代的黄嘌呤衍生物是吐痰的。 1,3,7,8取代的黄嘌呤衍生物对A_2A和A_2B AR具有良好的亲和力,并且对一个特定受体没有选择性。 这是对降低与CVS相关的副作用的好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号